Clinical Trials Directory

Trials / Unknown

UnknownNCT04128332

Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer

Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery in Pancreatic Adenocarcinoma: A Window of Opportunity Feasibility Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
CCTU- Cancer Theme · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

A window of opportunity feasibility study assessing pre-operative stereotactic ablative body radiotherapy followed by immediate surgery in pancreatic adenocarcinoma.

Detailed description

This is a single-centre, prospective, non-randomised feasibility study. This study will assess whether SABR can safely be given immediately prior to Whipple's resection by assessing the rate of post-operative complications.

Conditions

Interventions

TypeNameDescription
RADIATIONPre-operative stereotactic ablative body radiotherapyStereotactic ablative body radiotherapy is a highly focused radiation treatment that gives an intense dose of radiation concentrated on a tumour, while limiting the dose to the surrounding tissues.

Timeline

Start date
2020-10-26
Primary completion
2021-12-01
Completion
2022-12-01
First posted
2019-10-16
Last updated
2021-02-09

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04128332. Inclusion in this directory is not an endorsement.

Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer (NCT04128332) · Clinical Trials Directory